Testing effectiveness (Phase 2)Study completedNCT00243737What this trial is testingEfficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum MalariaWho this might be right forMalaria Albert Schweitzer Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01213966What this trial is testingEfficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infectionWho this might be right forMalaria, FalciparumMalaria, Vivax Medicines for Malaria Venture 82
Testing effectiveness (Phase 2)UnknownNCT01464125What this trial is testingFosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in AdultsWho this might be right forMalaria Jomaa Pharma GmbH 43
Large-scale testing (Phase 3)Study completedNCT00386763What this trial is testingEfficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.Who this might be right forMalariaFalciparum Novartis 890
Testing effectiveness (Phase 2)Study completedNCT00331136What this trial is testingPyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum MalariaWho this might be right forUncomplicated Plasmodium Falciparum Malaria Medicines for Malaria Venture 60
Large-scale testing (Phase 3)Study completedNCT01619878What this trial is testingEfficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kgWho this might be right forAcute Uncomplicated Falciparum Malaria Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT01464138What this trial is testingEvaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in ChildrenWho this might be right forMalaria Jomaa Pharma GmbH 52
Testing effectiveness (Phase 2)Ended earlyNCT02880241What this trial is testingMMV390048 POC in Patients With P. Vivax and P. Falciparum MalariaWho this might be right forMalaria Medicines for Malaria Venture 8
Post-approval studies (Phase 4)Study completedNCT00233337What this trial is testingEfficacy, Safety and Tolerability of Co-artemether in Non-immune TravelersWho this might be right forAcute Uncomplicated P. Falciparum Malaria Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00541385What this trial is testingPyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric PatientsWho this might be right forMalaria Medicines for Malaria Venture 535
Testing effectiveness (Phase 2)Study completedNCT01836458What this trial is testingFind the Minimum Inhibitory Concentration of KAE609 in Adult Male Patients With P. Falciparum MonoinfectionWho this might be right forMalaria Novartis Pharmaceuticals 25
Large-scale testing (Phase 3)Study completedNCT00709969What this trial is testingEvaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum MalariaWho this might be right forPlasmodium Falciparum Malaria Novartis 310
Not applicableStudy completedNCT00157859What this trial is testingTo Evaluate Current Efficacy of Antimalarials Used in Timika, Papua, IndonesiaWho this might be right forFalciparum MalariaVivax Malaria Menzies School of Health Research 150